If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names

Biotech stocks are not for the faint of heart. It is a sector that can provide life-changing gains or cause an investment to head towards zero. Between juggling FDA approvals, new product pipelines and regulatory changes, it takes a lot of due diligence to stay on top of which biotech stocks to buy. Some investors even go so far as to look into the more specific clinical phase trials and even learn about the specific medical technology behind each treatment. Over the past few months, biotech stocks have bee ...